Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up to $18.51

Pulse Biosciences, Inc. (NASDAQ:PLSE) shares gapped up prior to trading on Monday . The stock had previously closed at $18.51, but opened at $19.00. Pulse Biosciences shares last traded at $18.88, with a volume of 19,754 shares.

Analyst Ratings Changes

Separately, StockNews.com raised shares of Pulse Biosciences to a “sell” rating in a research report on Tuesday, August 6th.

Pulse Biosciences Price Performance

The company’s 50 day simple moving average is $17.30 and its 200 day simple moving average is $12.31. The firm has a market cap of $1.22 billion, a price-to-earnings ratio of -24.62 and a beta of 1.75.

Institutional Investors Weigh In On Pulse Biosciences

Hedge funds have recently made changes to their positions in the business. Rhumbline Advisers lifted its position in Pulse Biosciences by 6.7% in the second quarter. Rhumbline Advisers now owns 25,729 shares of the company’s stock valued at $288,000 after purchasing an additional 1,608 shares during the period. BNP Paribas Financial Markets increased its holdings in Pulse Biosciences by 63.6% in the first quarter. BNP Paribas Financial Markets now owns 7,597 shares of the company’s stock valued at $66,000 after buying an additional 2,952 shares in the last quarter. Quest Partners LLC purchased a new position in Pulse Biosciences in the second quarter valued at about $91,000. Bank of New York Mellon Corp increased its holdings in Pulse Biosciences by 23.4% in the second quarter. Bank of New York Mellon Corp now owns 50,914 shares of the company’s stock valued at $570,000 after buying an additional 9,639 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD purchased a new position in Pulse Biosciences in the first quarter valued at about $88,000. Institutional investors and hedge funds own 76.95% of the company’s stock.

About Pulse Biosciences

Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.